Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Regucalcin pseudogene (ENSG00000292329) refers to a non-functional genomic sequence resembling the coding regucalcin gene. It does not encode a protein and has no established role in cellular physiology or pathology. The functional regucalcin gene (RGN/SMP30) encodes a calcium-binding protein with roles in calcium homeostasis, signaling pathways, cell survival, apoptosis, and oxidative stress, and its dysregulation is implicated in cancer, aging, and other diseases. The pseudogene is not a therapeutic target nor a biomarker, and is not mentioned in expert databases as a druggable entity. If you are seeking information about the functional regucalcin gene (RGN), see references above for details on its roles in calcium signaling, aging, and cancer. However, ENSG00000292329 refers specifically to a pseudogene, which should not be mistaken for the functional protein or its molecular activities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Regucalcin pseudogene.